Premium
P3‐265: DIABETES MODERATES THE RATE OF FUNCTIONAL DECLINE IN COGNITIVELY NORMAL OLDER ADULTS AT RISK FOR ALZHEIMER'S DISEASE
Author(s) -
Thomas Kelsey R.,
Bangen Katherine J.,
Weigand Alexandra J.,
Eppig Joel S.,
Weharne Madeleine L.,
Edmonds Emily C.,
Sundermann Erin E.,
Wong Christina G.,
Delano-Wood Lisa,
Bondi Markus W.
Publication year - 2018
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2018.06.1625
Subject(s) - neurocognitive , dementia , cognitive decline , apolipoprotein e , disease , alzheimer's disease neuroimaging initiative , medicine , risk factor , diabetes mellitus , cognition , alzheimer's disease , psychology , gerontology , psychiatry , endocrinology
Alzheimer Center andDepartment of Neurology, AmsterdamNeuroscience, VU University Medical Center, Amsterdam, Netherlands; Alzheimer Center Limburg, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands; Department of Radiology and Nuclear Medicine, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, Netherlands; VU University Medical Center, Amsterdam, Netherlands; Department of Clinical Chemistry, Neurochemistry Laboratory and Biobank, VU University Medical Centre, Amsterdam, Netherlands. Contact e-mail: f.duits@vumc.nl